Chargement en cours...
Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
Inflammatory bowel disease (IBD) is a complex heterogeneous disorder defined by recurring chronic inflammation of the gastrointestinal tract, attributed to a combination of factors including genetic susceptibility, altered immune response, a shift in microbial composition/microbial insults (infectio...
Enregistré dans:
| Publié dans: | Microbiome Res Rep |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
OAE Publishing Inc.
2023
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615213/ https://ncbi.nlm.nih.gov/pubmed/37849974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/mrr.2023.41 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|